- Advertisement -

Find a job

Subscribe for free

All things Pharma


Daily news from the pharmaceutical and healthcare industries.


NICE commits to greater flexibility in its evaluation of new health technologies

The National Institute for Health and Care Excellence (NICE) is changing the way it evaluates medicines and other health technologies for use in the...

COVID-19 booster programme ramps up again following government announcement

People aged 30 and over are now able to book an appointment for their COVID-19 booster jab from today, as the NHS vaccine programme...


- Advertisement -
- Advertisement -

NICE recommends Tagrisso for patients with early-stage lung cancer

Following a positive final recommendation from the National Institute for Health and Care Excellence...

JCVI responds to Omicron variant and updates its guidance

The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of...

EC grants marketing authorisation for breast cancer treatment Trodelvy

The European Commission (EC) has granted marketing authorization for Gilead Sciences’ Trodelvy® (sacituzumab govitecan), as...


Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription